We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+0.74%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$136M
AUM Growth
+$5.95M
Cap. Flow
+$5.2M
Cap. Flow %
3.82%
Top 10 Hldgs %
22.74%
Holding
100
New
6
Increased
48
Reduced
19
Closed
1

Top Buys

Rank Stock Value
1
DE icon
Deere & Co
DE
+$1.6M
2
NEWS
NewStar Financial, Inc.
NEWS
+$586K
3
SO icon
Southern Company
SO
+$263K
4
MA icon
Mastercard
MA
+$225K
5
BA icon
Boeing
BA
+$208K

Sector Composition

Rank Sector Weight
1 Industrials 14.85%
2 Technology 12.94%
3 Healthcare 11.18%
4 Consumer Staples 10.76%
5 Financials 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYG icon
26
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$2.16M 1.59%
22,908
+50
+0.2% +$4.69K
MA icon
27
Mastercard
MA
$497B
$2.16M 1.59%
28,895
+2,885
+11% +$225K
XLU icon
28
State Street Utilities Select Sector SPDR ETF
XLU
$23.4B
$2.14M 1.57%
103,292
-2,248
-2% -$44.3K
CVS icon
29
CVS Health
CVS
$140B
$2.12M 1.56%
28,325
-292
-1% -$20.6K
UPS icon
30
United Parcel Service
UPS
$89.7B
$2.11M 1.55%
21,631
+860
+4% +$83.8K
ACN icon
31
Accenture
ACN
$101B
$2.02M 1.49%
25,411
-320
-1% -$26.3K
CL icon
32
Colgate-Palmolive
CL
$74.2B
$2M 1.47%
30,880
+350
+1% +$22.1K
ADP icon
33
Automatic Data Processing
ADP
$106B
$1.96M 1.44%
28,859
-171
-0.6% -$11.6K
COV
34
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$1.93M 1.42%
26,266
-217
-0.8% -$15.1K
BNY
35
Bank of New York Mellon
BNY
$106B
$1.92M 1.41%
54,488
+580
+1% +$19.2K
CHRW icon
36
C.H. Robinson
CHRW
$20B
$1.9M 1.39%
36,220
+1,060
+3% +$57.7K
EWC icon
37
iShares MSCI Canada ETF
EWC
$6.18B
$1.86M 1.37%
62,955
+210
+0.3% +$6.05K
COP icon
38
ConocoPhillips
COP
$139B
$1.86M 1.37%
26,400
+821
+3% +$55K
VB icon
39
Vanguard Small-Cap ETF
VB
$80.2B
$1.85M 1.36%
16,358
-80
-0.5% -$8.87K
CMCSK
40
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$1.82M 1.34%
37,293
+900
+2% +$43.9K
EFA icon
41
iShares MSCI EAFE ETF
EFA
$76.8B
$1.76M 1.3%
26,244
+460
+2% +$30.4K
DE icon
42
Deere & Co
DE
$173B
$1.66M 1.22%
+18,272
New +$1.6M
T icon
43
AT&T
T
$169B
$1.66M 1.22%
62,535
+2,815
+5% +$70.7K
IJR icon
44
iShares Core S&P Small-Cap ETF
IJR
$110B
$1.64M 1.2%
29,720
OIH icon
45
VanEck Oil Services ETF
OIH
$1.99B
$1.63M 1.2%
1,619
+41
+3% +$38.9K
OMC icon
46
Omnicom Group
OMC
$24.6B
$1.54M 1.13%
21,184
-416
-2% -$30.6K
ABBV icon
47
AbbVie
ABBV
$465B
$1.42M 1.04%
27,572
+169
+0.6% +$8.54K
CVX icon
48
Chevron
CVX
$374B
$1.32M 0.97%
11,149
+200
+2% +$23.3K
XLE icon
49
State Street Energy Select Sector SPDR ETF
XLE
$38.3B
$1.32M 0.97%
29,724
ABT icon
50
Abbott
ABT
$187B
$1.17M 0.86%
30,392
+538
+2% +$20.7K

Similar funds

Boston Research & Management's Q1 2014 Portfolio in Review

As of Q1 2014, Boston Research & Management held 100 positions worth $136M, up 4.6% from $130M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Boston Research & Management deployed $5.2M of net new capital in Q1 2014, opening 6 new positions and adding to 48 existing holdings. Its largest new stake was Deere & Co: 18,272 shares worth $1.66M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $117K trimmed.

  • Boston Research & Management's largest Q1 2014 buy was Deere & Co: 18,272 shares worth $1.66M.
  • Boston Research & Management added most to Mastercard in Q1 2014, an estimated $225K increase.
  • Boston Research & Management's biggest Q1 2014 reduction was Alphabet (Google) Class C, cutting an estimated $117K.
  • Boston Research & Management's ten largest holdings make up 23% of its $136M portfolio in Q1 2014.
  • Boston Research & Management opened 6 new positions and closed 1 in Q1 2014.
  • Boston Research & Management's portfolio value rose 4.6% quarter-over-quarter to $136M.

Based on Boston Research & Management's 13F filing for Q1 2014, filed 13 May 2014.